Wellspring Financial Advisors LLC Makes New $805,000 Investment in Danaher Corporation $DHR

Wellspring Financial Advisors LLC purchased a new position in Danaher Corporation (NYSE:DHR) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 3,517 shares of the conglomerate’s stock, valued at approximately $805,000.

Other hedge funds have also made changes to their positions in the company. JPL Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC bought a new stake in shares of Danaher in the 4th quarter worth approximately $26,000. WFA of San Diego LLC bought a new stake in shares of Danaher in the 2nd quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher in the 3rd quarter worth approximately $27,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher in the 4th quarter worth approximately $27,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on DHR. Evercore raised their price target on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a report on Tuesday, April 21st. Argus cut their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. JPMorgan Chase & Co. cut their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Finally, DZ Bank began coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $235.14.

Danaher Stock Down 2.4%

Shares of DHR stock opened at $183.88 on Thursday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market cap of $130.14 billion, a PE ratio of 35.57, a price-to-earnings-growth ratio of 2.52 and a beta of 0.81. The business’s fifty day moving average is $181.33 and its 200-day moving average is $205.28. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same period last year, the firm earned $1.88 EPS. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. Equities analysts expect that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.